Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice
Author(s) -
Yanli Song,
John E. Jones,
Hideyuki Beppu,
John F. Keaney,
Joseph Loscalzo,
Yingyi Zhang
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.492488
Subject(s) - bmpr2 , medicine , prostacyclin , pulmonary hypertension , endocrinology , thromboxane , lung , biology , bone morphogenetic protein , platelet , biochemistry , gene
Bone morphogenetic protein receptor-2 (BMPR2)-heterozygous, mutant (BMPR2(+/-)) mice have a genetic trait similar to that of certain patients with idiopathic pulmonary arterial hypertension (IPAH). To understand the role of BMPR2 in the development of IPAH, we examined the phenotype of BMPR2(+/-) mice and their response to inflammatory stress.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom